Intech Biopharm Ltd(TW:6461)
NT$26.20-0.35 (-1.32%)
TW:6461
Intech Biopharm Ltd financials statements
NT$26.20
At close:-0.35 (-1.32%)
Intech Biopharm Ltd (6461) Income Statement
Intech Biopharm Ltd Income Statement
Last quarter (Q2 2026), Intech Biopharm Ltd's total revenue was NT$18.83M, a decrease of 78.54% from the same quarter last year. In Q2, Intech Biopharm Ltd's net income was NT$-102.70M. See Intech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 107.53M | NT$ 39.78M | NT$ 25.85M | NT$ 23.65M | NT$ 38.90M | |
| NT$ -120.12M | NT$ -157.63M | NT$ -164.00M | NT$ -147.26M | NT$ -119.37M | |
| NT$ 244.38M | NT$ 198.50M | NT$ -164.00M | NT$ 170.82M | NT$ 174.61M | |
| Depreciation and Amortization | NT$ 91.26M | NT$ 87.35M | NT$ 84.81M | NT$ 85.36M | NT$ 85.30M |
| NT$ -273.24M | NT$ -246.70M | NT$ -219.59M | NT$ -219.48M | NT$ -197.40M | |
| NT$ -364.50M | NT$ -356.13M | NT$ -320.47M | NT$ -304.84M | NT$ -282.22M | |
| NT$ -17.73M | NT$ -12.08M | NT$ -17.52M | NT$ -9.80M | NT$ -19.54M | |
| NT$ -382.23M | NT$ -368.21M | NT$ -337.99M | NT$ -327.88M | NT$ -301.76M | |
| NT$ -389.03M | NT$ -368.21M | NT$ -337.99M | NT$ -327.88M | NT$ -301.76M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -4.14 | NT$ -4.34 | NT$ -4.55 | NT$ -4.56 | NT$ -4.68 |
| Diluted EPS | NT$ -4.14 | NT$ -4.34 | NT$ -4.55 | NT$ -4.56 | NT$ -4.68 |
| Weighted Average Shares Outstanding | 93.73M | 84.84M | 74.33M | 71.77M | 64.52M |
| Weighted Average Shares Outstanding (Diluted) | 93.73M | 84.84M | 74.33M | 71.77M | 64.52M |
Currency in TWD

